Ontex Group (ENXTBR:ONTEX) Is Down 25.3% After CEO Transition And Revenue Cut News – Has The Bull Case Changed?

• Ontex Group has announced that Europe Division President Laurent Nielly will succeed Gustavo Calvo Paz as CEO after the May 5, 2026 shareholders’ meeting, while also cutting its 2025 revenue outlook and warning of a high single digit like-for-like revenue drop in the fourth quarter versus last year.
• At the same time, Ontex is tripling baby pants production capacity in North America to support retailer-brand growth in a segment where U.S. consumers are increasingly opting for affordable, premium-quality store brands.
• We’ll now examine how the CEO transition, alongside lowered revenue guidance, reshapes Ontex’s investment narrative and future execution priorities.

Trump's oil boom is here - pipelines are primed to profit. Discover the 22 US stocks riding the wave.

What Is Ontex Group's Investment Narrative?

To own Ontex today, you need to believe the company can convert its repositioning around private-label hygiene into steadier profits despite choppy execution. The sudden cut to 2025 revenue guidance and warning of a high single digit Q4 decline reset expectations and help explain the sharp share price fall, but they also sharpen the focus on near term catalysts: stabilizing like-for-like sales, proving that new North American capacity fills profitably, and showing early benefits from recent product launches. The planned 2026 CEO transition to Laurent Nielly adds continuity rather than disruption, given his internal track record, yet it also raises the bar on fixing low margins and high leverage. In the short run, revenue visibility and balance sheet risk now matter more than any long term growth story.

However, one issue could quietly limit upside if conditions do not improve. Despite retreating, Ontex Group's shares might still be trading above their fair value and there could be some more downside. Discover how much.

Exploring Other Perspectives

Five fair value estimates from the Simply Wall St Community span roughly €6.93 to about €19.10, reflecting very different expectations for Ontex’s recovery potential. Set this against the recent revenue downgrade and high debt load, and you can see why opinions diverge so sharply on how quickly the business can repair margins and rebuild confidence.

Explore 5 other fair value estimates on Ontex Group - why the stock might be worth over 3x more than the current price!

Build Your Own Ontex Group Narrative

Disagree with this assessment? Create your own narrative in under 3 minutes - extraordinary investment returns rarely come from following the herd.

• A great starting point for your Ontex Group research is our analysis highlighting 3 key rewards and 4 important warning signs that could impact your investment decision.
• Our free Ontex Group research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Ontex Group's overall financial health at a glance.

Looking For Alternative Opportunities?

Every day counts. These free picks are already gaining attention. See them before the crowd does:

• Find companies with promising cash flow potential yet trading below their fair value.
• AI is about to change healthcare. These 30 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
• Explore 27 top quantum computing companies leading the revolution in next-gen technology and shaping the future with breakthroughs in quantum algorithms, superconducting qubits, and cutting-edge research.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com